OTLC
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Apr 11 closing price
Capitalization
21M
37 days until earnings call
TENX
Price
$5.56
Change
+$0.21 (+3.93%)
Updated
Apr 11 closing price
Capitalization
22.05M
Ad is loading...

OTLC vs TENX

Header iconOTLC vs TENX Comparison
Open Charts OTLC vs TENXBanner chart's image
Oncotelic Therapeutics
Price$0.05
Change-$0.00 (-0.00%)
Volume$401.06K
Capitalization21M
Tenax Therapeutics
Price$5.56
Change+$0.21 (+3.93%)
Volume$4.09K
Capitalization22.05M
OTLC vs TENX Comparison Chart
Loading...
OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OTLC vs. TENX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OTLC is a Hold and TENX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 12, 2025
Stock price -- (OTLC: $0.05 vs. TENX: $5.56)
Brand notoriety: OTLC and TENX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OTLC: 279% vs. TENX: 10%
Market capitalization -- OTLC: $21M vs. TENX: $22.05M
OTLC [@Biotechnology] is valued at $21M. TENX’s [@Biotechnology] market capitalization is $22.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.66B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OTLC’s FA Score shows that 0 FA rating(s) are green whileTENX’s FA Score has 1 green FA rating(s).

  • OTLC’s FA Score: 0 green, 5 red.
  • TENX’s FA Score: 1 green, 4 red.
According to our system of comparison, TENX is a better buy in the long-term than OTLC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OTLC’s TA Score shows that 3 TA indicator(s) are bullish while TENX’s TA Score has 5 bullish TA indicator(s).

  • OTLC’s TA Score: 3 bullish, 5 bearish.
  • TENX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TENX is a better buy in the short-term than OTLC.

Price Growth

OTLC (@Biotechnology) experienced а -12.63% price change this week, while TENX (@Biotechnology) price change was -4.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.15%. For the same industry, the average monthly price growth was -16.20%, and the average quarterly price growth was -17.21%.

Reported Earning Dates

OTLC is expected to report earnings on May 19, 2025.

TENX is expected to report earnings on Apr 03, 2023.

Industries' Descriptions

@Biotechnology (+0.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TENX($22M) and OTLC($21M) have the same market capitalization . OTLC YTD gains are higher at: 47.286 vs. TENX (-10.178). OTLC has higher annual earnings (EBITDA): -4.05M vs. TENX (-14.53M). TENX has more cash in the bank: 98.3M vs. OTLC (149K). TENX has less debt than OTLC: TENX (279K) vs OTLC (12.9M). OTLC (0) and TENX (0) have equivalent revenues.
OTLCTENXOTLC / TENX
Capitalization21M22M95%
EBITDA-4.05M-14.53M28%
Gain YTD47.286-10.178-465%
P/E RatioN/AN/A-
Revenue00-
Total Cash149K98.3M0%
Total Debt12.9M279K4,624%
FUNDAMENTALS RATINGS
OTLC vs TENX: Fundamental Ratings
OTLC
TENX
OUTLOOK RATING
1..100
8466
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
10
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9493
PRICE GROWTH RATING
1..100
3544
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TENX's Valuation (10) in the Medical Specialties industry is somewhat better than the same rating for OTLC (59) in the null industry. This means that TENX’s stock grew somewhat faster than OTLC’s over the last 12 months.

TENX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as OTLC (100) in the null industry. This means that TENX’s stock grew similarly to OTLC’s over the last 12 months.

TENX's SMR Rating (93) in the Medical Specialties industry is in the same range as OTLC (94) in the null industry. This means that TENX’s stock grew similarly to OTLC’s over the last 12 months.

OTLC's Price Growth Rating (35) in the null industry is in the same range as TENX (44) in the Medical Specialties industry. This means that OTLC’s stock grew similarly to TENX’s over the last 12 months.

OTLC's P/E Growth Rating (94) in the null industry is in the same range as TENX (100) in the Medical Specialties industry. This means that OTLC’s stock grew similarly to TENX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OTLCTENX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
83%
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FRO15.501.47
+10.48%
Frontline Plc
IRON38.733.50
+9.93%
Disc Medicine
HIVE1.480.05
+3.50%
HIVE Digital Technologies Ltd
AMX14.190.27
+1.94%
America Movil SAB de CV
FBRX5.25-0.64
-10.87%
Forte Biosciences Inc

OTLC and

Correlation & Price change

A.I.dvisor tells us that OTLC and TENX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OTLC and TENX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLC
1D Price
Change %
OTLC100%
+3.31%
TENX - OTLC
23%
Poorly correlated
+3.93%
MNKD - OTLC
22%
Poorly correlated
+0.43%
IMTX - OTLC
21%
Poorly correlated
+4.28%
MMIRF - OTLC
15%
Poorly correlated
N/A
IUGNF - OTLC
13%
Poorly correlated
-22.00%
More

TENX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TENX has been loosely correlated with AVXL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TENX jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TENX
1D Price
Change %
TENX100%
+3.93%
AVXL - TENX
47%
Loosely correlated
+3.75%
SBHMY - TENX
42%
Loosely correlated
N/A
CORT - TENX
41%
Loosely correlated
+1.31%
ADVM - TENX
36%
Loosely correlated
+3.00%
COYA - TENX
35%
Loosely correlated
+4.87%
More